Type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema (bilateral)
ICD-10 E10.3413 is a billable code used to indicate a diagnosis of type 1 diabetes mellitus with severe nonproliferative diabetic retinopathy with macular edema (bilateral).
E10.3413 refers to a specific condition in which a patient has Type 1 diabetes mellitus accompanied by severe nonproliferative diabetic retinopathy (NPDR) and bilateral macular edema. Type 1 diabetes is characterized by the autoimmune destruction of insulin-producing beta cells in the pancreas, leading to absolute insulin deficiency. Diabetic retinopathy is a common complication of diabetes, resulting from damage to the retinal blood vessels due to chronic hyperglycemia. Severe NPDR indicates significant retinal changes, including extensive retinal hemorrhages and exudates, while macular edema refers to the accumulation of fluid in the macula, the central part of the retina responsible for sharp vision. This condition can lead to vision impairment and requires careful management of blood glucose levels, often necessitating insulin therapy and regular ophthalmologic evaluations. The presence of bilateral macular edema further complicates the clinical picture, as it can significantly affect visual acuity and quality of life.
Detailed records of diabetes management, including insulin types, dosages, and HbA1c levels.
Patients presenting with uncontrolled diabetes, requiring insulin adjustments and monitoring for complications.
Ensure comprehensive documentation of diabetes management and any referrals to ophthalmology.
Thorough retinal examination findings, including descriptions of NPDR and macular edema.
Patients with diabetes presenting for routine eye exams or with vision changes.
Document the severity of retinopathy and any treatments provided, such as laser therapy.
Used for routine eye exams in patients with diabetes.
Document the findings of the eye exam, including retinopathy severity.
Ophthalmologists should ensure detailed notes on retinal findings.
Coding E10.3413 accurately reflects the severity of diabetic retinopathy and the presence of macular edema, which are critical for appropriate management and treatment planning.
Patients should be monitored regularly, typically every 6 to 12 months, depending on the severity of their retinopathy and overall diabetes control.
